Literature DB >> 10992477

Tumor necrosis factor alpha p55 receptor is important for development of memory responses to blood-stage malaria infection.

C Li1, J Langhorne.   

Abstract

Tumor necrosis factor alpha (TNF-alpha) is associated with malarial pathology in both humans and mice. In Plasmodium chabaudi chabaudi (AS) infections, the production of TNF-alpha and reactive metabolites from macrophages are also thought to play a role in controlling acute parasitemia. Since many of the biological functions of TNF-alpha are effected through the p55 receptor (p55R), mice made defective in this receptor via a targeted gene disruption (p55R(-/-)) have been used to study its involvement in the immune response against P. chabaudi chabaudi and in the pathology associated with this infection. In the absence of the p55R, mice could overcome their primary infection, although higher acute-blood-stage parasitemias and more significant recrudescences were observed. Hypoglycemia, hypothermia, loss of erythrocytes, and loss of body weight, which occur transiently in this infection, were exacerbated by the lack of the p55R, but the differences were small, suggesting that other factors affect these symptoms. In contrast to wild-type (WT) mice, a second challenge infection in p55R(-/-) mice resulted in a course of infection similar to a primary infection. The malaria-specific immunoglobulin G antibody response of p55R(-/-) mice was lower than that of WT mice and was not increased by the second challenge infection. These data suggest that p55R(-/-) mice do not develop an efficient memory B-cell response against malarial infection and that this antibody response is important in immunity to reinfection.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10992477      PMCID: PMC101529          DOI: 10.1128/IAI.68.10.5724-5730.2000

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  58 in total

1.  Killing of Plasmodium falciparum in vitro by nitric oxide derivatives.

Authors:  K A Rockett; M M Awburn; W B Cowden; I A Clark
Journal:  Infect Immun       Date:  1991-09       Impact factor: 3.441

2.  Limiting dilution analysis of the T cell response to Plasmodium chabaudi chabaudi in mice.

Authors:  J Langhorne; B Simon
Journal:  Parasite Immunol       Date:  1989-09       Impact factor: 2.280

3.  Control of Leishmania major infection in mice lacking TNF receptors.

Authors:  M Nashleanas; S Kanaly; P Scott
Journal:  J Immunol       Date:  1998-06-01       Impact factor: 5.422

4.  The effect of a monoclonal antibody to tumor necrosis factor on survival from childhood cerebral malaria.

Authors:  M B van Hensbroek; A Palmer; E Onyiorah; G Schneider; S Jaffar; G Dolan; H Memming; J Frenkel; G Enwere; S Bennett; D Kwiatkowski; B Greenwood
Journal:  J Infect Dis       Date:  1996-11       Impact factor: 5.226

Review 5.  Germinal centers.

Authors:  I C MacLennan
Journal:  Annu Rev Immunol       Date:  1994       Impact factor: 28.527

6.  Crucial role of TNF receptor type 1 (p55), but not of TNF receptor type 2 (p75), in murine toxoplasmosis.

Authors:  M Deckert-Schlüter; H Bluethmann; A Rang; H Hof; D Schlüter
Journal:  J Immunol       Date:  1998-04-01       Impact factor: 5.422

7.  Tumor necrosis factor-alpha is required in the protective immune response against Mycobacterium tuberculosis in mice.

Authors:  J L Flynn; M M Goldstein; J Chan; K J Triebold; K Pfeffer; C J Lowenstein; R Schreiber; T W Mak; B R Bloom
Journal:  Immunity       Date:  1995-06       Impact factor: 31.745

8.  Plasmodium chabaudi chabaudi (AS): inflammatory cytokines and pathology in an erythrocytic-stage infection in mice.

Authors:  C E Cross; J Langhorne
Journal:  Exp Parasitol       Date:  1998-11       Impact factor: 2.011

9.  Anaemia and resistance to malaria in transgenic mice expressing human tumour necrosis factor.

Authors:  J Taverne; N Sheikh; J B de Souza; J H Playfair; L Probert; G Kollias
Journal:  Immunology       Date:  1994-07       Impact factor: 7.397

10.  Susceptibility to Salmonella typhimurium infection and effectiveness of vaccination in mice deficient in the tumor necrosis factor alpha p55 receptor.

Authors:  P Everest; M Roberts; G Dougan
Journal:  Infect Immun       Date:  1998-07       Impact factor: 3.441

View more
  15 in total

1.  Small variant STEVOR antigen is uniquely located within Maurer's clefts in Plasmodium falciparum-infected red blood cells.

Authors:  M Kaviratne; S M Khan; W Jarra; P R Preiser
Journal:  Eukaryot Cell       Date:  2002-12

Review 2.  Cytokines in the pathogenesis of and protection against malaria.

Authors:  Iñigo Angulo; Manuel Fresno
Journal:  Clin Diagn Lab Immunol       Date:  2002-11

3.  A defunctioning polymorphism in FCGR2B is associated with protection against malaria but susceptibility to systemic lupus erythematosus.

Authors:  Lisa C Willcocks; Edward J Carr; Heather A Niederer; Tim F Rayner; Thomas N Williams; Wanling Yang; J Anthony G Scott; Britta C Urban; Norbert Peshu; Timothy J Vyse; Yu Lung Lau; Paul A Lyons; Kenneth G C Smith
Journal:  Proc Natl Acad Sci U S A       Date:  2010-04-12       Impact factor: 11.205

4.  Adjuvant-like effect of vaccinia virus 14K protein: a case study with malaria vaccine based on the circumsporozoite protein.

Authors:  Aneesh Vijayan; Carmen E Gómez; Diego A Espinosa; Alan G Goodman; Lucas Sanchez-Sampedro; Carlos Oscar S Sorzano; Fidel Zavala; Mariano Esteban
Journal:  J Immunol       Date:  2012-05-21       Impact factor: 5.422

5.  Different regions of the malaria merozoite surface protein 1 of Plasmodium chabaudi elicit distinct T-cell and antibody isotype responses.

Authors:  S J Quin; J Langhorne
Journal:  Infect Immun       Date:  2001-04       Impact factor: 3.441

6.  Suppression of Plasmodium chabaudi parasitemia is independent of the action of reactive oxygen intermediates and/or nitric oxide.

Authors:  Brad M Gillman; Joan Batchelder; Patrick Flaherty; William P Weidanz
Journal:  Infect Immun       Date:  2004-11       Impact factor: 3.441

7.  CD28 costimulation is required for the expression of T-cell-dependent cell-mediated immunity against blood-stage Plasmodium chabaudi malaria parasites.

Authors:  Thomas Rummel; Joan Batchelder; Patrick Flaherty; GayeLyn LaFleur; Payal Nanavati; James M Burns; William P Weidanz
Journal:  Infect Immun       Date:  2004-10       Impact factor: 3.441

Review 8.  Pathogenesis of malaria and clinically similar conditions.

Authors:  Ian A Clark; Lisa M Alleva; Alison C Mills; William B Cowden
Journal:  Clin Microbiol Rev       Date:  2004-07       Impact factor: 26.132

9.  Systemic lupus erythematosus-associated defects in the inhibitory receptor FcgammaRIIb reduce susceptibility to malaria.

Authors:  Menna R Clatworthy; Lisa Willcocks; Britta Urban; Jean Langhorne; Tom N Williams; Norbert Peshu; Nicholas A Watkins; R Andres Floto; Kenneth G C Smith
Journal:  Proc Natl Acad Sci U S A       Date:  2007-04-13       Impact factor: 11.205

10.  Homeostatic proliferation and IL-7R alpha expression do not correlate with enhanced T cell proliferation and protection in chronic mouse malaria.

Authors:  Robin Stephens; Benedict Seddon; Jean Langhorne
Journal:  PLoS One       Date:  2011-10-21       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.